FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. ADI
6. MRK
7. MRNA
8. WMT
9. ROST
10. NTES

Go back to FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.42 +0.30 (2.48%)
Previous Close $12.12    52 Week High $2.18 
Open $12.26    52 Week Low $0.30 
Day High $12.48    P/E N/A 
Day Low $12.06    EPS $-3.32 
Volume 357,040